As Skp2 is often activated in human cancers to increase cell proliferation through genetic amplification [41] and/or upregulated PI3K/Akt signaling [42], the dynamics of Skp2 and β-TrCP interactions is distinct in cancer cells to maintain protein homeostasis. The gene discussed is BTRC; the disease is cancer.